28 Apr 2021 TI Methods Speaker Series: The PRISMA 2020 Statement
Matt Page
In this presentation, Dr. Page described the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. The checklist includes new reporting guidance that reflects advances in methods to identify, select, appraise and synthesise studies. Scroll down to read the abstract for this presentation.
This webinar has already taken place. Please scroll down to view a video recording of the event.
WHEN: Wednesday, April 28th, 2021 from 2:00 to 3:00 PM PDT [click here to convert to your local time]
WHERE: Offered online using Zoom.
TITLE: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
SPEAKER: Dr. Matthew Page, Senior Research Fellow in the School of Public Health and Preventive Medicine at Monash University, Melbourne, Australia.
About the speaker: Dr. Matthew Page is a Senior Research Fellow in the School of Public Health and Preventive Medicine at Monash University, funded by an ARC Discovery Early Career Researcher Award. His current research interests include examining the transparency and reproducibility of systematic reviews and developing methods to address reporting biases (e.g. publication bias, selective reporting bias) in syntheses. He was an associate scientific editor for the 2019 edition of the Cochrane Handbook for Systematic Reviews of Interventions and is a co-convenor of the Cochrane Bias Methods Group. He frequently collaborates with clinicians on systematic reviews of interventions for a range of conditions, which often informs his research agenda.
About the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic, while physical distancing measures are in effect, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
Abstract
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372.n71. DOI: 10.1136/bmj.n71
Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did and what they found. Over the last decade, there have been many advances in systematic review methodology and terminology, which have necessitated an update to the guideline.
Objectives: To develop the PRISMA 2020 statement for reporting systematic reviews.
Methods: We reviewed 60 documents with reporting guidance for systematic reviews to generate suggested modifications to the PRISMA 2009 statement. We sought feedback on the suggested modifications through an online survey of 110 systematic review methodologists and journal editors. The results of the review and survey were discussed at a 21-member in-person meeting. Following the meeting, drafts of the PRISMA 2020 checklist, abstract checklist, explanation and elaboration and flow diagram were generated and refined iteratively based on feedback from co-authors and a convenience sample of 15 systematic reviewers.
Results: In this statement paper, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. The checklist includes new reporting guidance that reflects advances in methods to identify, select, appraise and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. The PRISMA 2020 statement replaces the 2009 statement.
Conclusions: The PRISMA 2020 statement is intended to facilitate transparent, complete and accurate reporting of systematic reviews. Improved reporting should benefit users of reviews, including guideline developers, policy makers, health care providers, patients and other stakeholders. In order to achieve this, we encourage authors, editors and peer-reviewers to adopt the guideline.
No Comments